Bevacizumab is used to treat which diabetic complication?

Bevacizumab is used to treat which diabetic complication?

• A. Bevacizumab
• B. Prednisone
• C. Amlodipine
• D. Insulin

Answer: (A)

Bevacizumab works by blocking VEGF, which drives abnormal blood vessel growth and leakage in diabetic retinopathy. By inhibiting VEGF, it reduces retinal neovascularization and vascular permeability, helping to stabilize or improve vision in conditions like proliferative diabetic retinopathy and diabetic macular edema. This is typically given as an intravitreal injection, often used when laser therapy isn’t enough or as an adjunct to reduce edema and prevent vision loss. The other drugs listed aren’t targeted treatments for this eye complication: prednisone is a systemic anti-inflammatory steroid, amlodipine is a calcium channel blocker for blood pressure, and insulin controls blood sugar but doesn’t directly address the retinal vascular changes.

Bevacizumab works by blocking VEGF, which drives abnormal blood vessel growth and leakage in diabetic retinopathy. By inhibiting VEGF, it reduces retinal neovascularization and vascular permeability, helping to stabilize or improve vision in conditions like proliferative diabetic retinopathy and diabetic macular edema. This is typically given as an intravitreal injection, often used when laser therapy isn’t enough or as an adjunct to reduce edema and prevent vision loss. The other drugs listed aren’t targeted treatments for this eye complication: prednisone is a systemic anti-inflammatory steroid, amlodipine is a calcium channel blocker for blood pressure, and insulin controls blood sugar but doesn’t directly address the retinal vascular changes.